Company Filing History:
Years Active: 2022
Title: Innovations by Fouad Yousif in Cancer Treatment
Introduction
Fouad Yousif is an accomplished inventor based in Burlington, CA. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. His work focuses on improving the efficacy of anthracycline treatment for cancer patients.
Latest Patents
Fouad Yousif holds a patent for "Methods and devices for predicting anthracycline treatment efficacy." This invention features methods, devices, and kits designed to predict the responsiveness of cancer patients, particularly breast cancer patients, to anthracycline treatment. By determining the expression levels of four chromosomal instability (CIN) genes, namely HDGF, KIAA0286, RFC4, and MSH6, collectively referred to as CIN4, the invention provides valuable insights. Patients with a low CIN4 score are shown to benefit more from anthracycline treatment compared to those with a high CIN4 score.
Career Highlights
Fouad Yousif is associated with the Ontario Institute for Cancer Research, where he continues to advance his research in cancer treatment. His dedication to improving patient outcomes through innovative methods is commendable.
Collaborations
Fouad has collaborated with notable colleagues, including Melanie Spears and John Bartlett, to further enhance the impact of his research in the field of oncology.
Conclusion
Fouad Yousif's innovative work in predicting anthracycline treatment efficacy represents a significant advancement in cancer treatment. His contributions are vital for improving patient care and outcomes in oncology.